are developed, manufactured & commercialized. |
 Novavax and Xcellerex announce collaboration to develop large-scale manufacturing process for 2009 H1N1 Influenza VLP Vaccine.more Itero Biopharmaceuticals selects Xcellerex to enable cost effective production of specialty biopharmaceutical protein products more Xcellerex announces milestone sale of FlexFactory® biomanufacturing line and XDR single-use bioreactors to Crucell, N.V. more 
|
 |